Psoria-Shield, Inc. Accepted Into MATTER Healthcare Technology Incubator


SCHAUMBURG, Ill., April 7, 2015 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB:WCUI), today announced that its wholly owned subsidiary, Psoria-Shield, Inc., has been accepted into MATTER, the nation's newest healthcare technology incubator, focused on next-generation health IT, medical device, bio/pharma and diagnostic innovation.

Launched in February 2015, MATTER is a not-for-profit organization developed by a team of entrepreneurs and industry leaders. MATTER received $4 million from the state of Illinois to help launch MATTER and over $4 million in support from more than 30 industry partners. MATTER began as a project of ChicagoNEXT, Mayor Emanuel's council on technology and innovation.

The full list of MATTER partners can be viewed at: http://www.matterchicago.com/partners/.

"We are very excited to have been selected to be a part of the MATTER community," stated Dr. Jay Joshi, the chief medical officer for Wellness Center USA, Inc. "Not all applicants are offered the opportunity to be a part of this incubator. Companies, institutions, the media, universities, and investors are all desperately looking for healthcare innovation, but don't know where to look. We believe that these entities will be very excited to learn more about our advanced medical device."

He continued by adding "Psoria-Shield's medical device, Psoria-Light®, is a disruptive technology that can change the way certain skin diseases are managed and treated. It can reduce costs, reduce side effects, and provide relief for patients who may be suffering. We believe as members of MATTER, we will have additional exposure that will continue to validate our technologies and provide a national platform for exposure that these technologies deserve."

Psoria-Shield's FDA cleared, patent-pending flagship product, Psoria-Light®, is the first Deep UV LED "Targeted Phototherapy" device to effectively treat Psoriasis, Eczema, Vitiligo, and other auto-immune skin diseases. Psoria-Light® has FDA clearance, is CE marked, and is ISO 13485 certified. It has been used on patients both in America and Mexico with stellar outcomes and no complications. A medical assistant can administer the treatment, thus freeing the physician. Psoria-Light® is also covered by commercial insurance and Medicare.

About Wellness Center USA, Inc.

Wellness Center USA, Inc. (www.wellnesscenterusa.com) is a hybrid healthcare company that combines best in class technologies, software, devices, providers, protocols, goods, and services. It was created to address important healthcare and wellness needs via breakthrough solutions, all centered around the "well-being of the body and mind". Wellness Center USA, Inc. is the parent company of three businesses reporting consolidated: Stealth Mark, National Pain Centers, and Psoria-Shield.

About MATTER

MATTER is a community of healthcare entrepreneurs and industry leaders working together in a shared space to individually and collectively fuel the future of healthcare innovation. MATTER's mission is to proactively connect and promote collaboration between entrepreneurs, scientists, physicians and industry partners in order to bring next-generation products and services to market that improve quality of care and save lives. For more information, visit http://www.matterchicago.com and follow @matterchicago.

Safe Harbor Statement:

Certain statements and projections contained in this presentation that are not statements or financial results of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements and projections include statements regarding any proposed exchange transactions, the anticipated closing date of such transactions and future results following a closing of the transactions. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like "believe," "expect," "anticipate," "pending", "estimate," and "intend" or future or conditional verbs such as "will," "would," "should," "could," or "may." While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transactions and plans which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transactions, difficulties in integrating operations following the transactions, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.


            

Contact Data